XML 44 R37.htm IDEA: XBRL DOCUMENT

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Schedule of Earnings Per Share, Basic and Diluted

The following is a summary of the basic and diluted net loss per share computation for the periods presented:



	Three Months Ended March 31,
	2020			2019
Net loss attributable to stockholders (in thousands)	$	(24,744	)	$	(5,111	)
Basic and diluted weighted-average shares outstanding	91,960,960			92,894,608
Basic and diluted net loss per share	$	(0.27	)	$	(0.06	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following common stock equivalents on a weighted-average basis that were excluded from the calculation of diluted net loss per share attributable to stockholders as their effect would have been antidilutive for the periods presented:



	Three Months Ended March 31,
	2020	2019
Unvested restricted shares ⁽¹⁾	277,241	322,242
OP Units ⁽²⁾	405,998	405,998
Class B Units ⁽³⁾	359,250	359,250
Total weighted average antidilutive common stock equivalents	1,042,489	1,087,490

_________


⁽¹⁾	Weighted average number of antidilutive unvested restricted shares outstanding for the periods presented. There were 277,241 and 322,242 unvested restricted shares outstanding as of March 31, 2020 and 2019, respectively.

⁽²⁾ Weighted average number of antidilutive OP Units outstanding for the periods presented. There were 405,998 OP Units outstanding as of March 31, 2020 and 2019.

⁽³⁾

Weighted average number of antidilutive Class B Units outstanding for the periods presented. There were 359,250 Class B Units outstanding as of March 31, 2020 and 2019. These Class B Units are unvested as of March 31, 2020 and 2019 (see Note 9 — Related Party Transactions for additional information).